Description

Health Canada has notified Jennewein Biotechnologie, GmbH, that it has no objection to the use of 2'-fucosyllactose (2'-FL) derived from a genetically modified strain of E. coli BL21 (DE3), "the production strain" or "the strain", as an ingredient for infant formula. The Department conducted a comprehensive assessment of this oligosaccharide according to its Guidelines for the Safety Assessment of Novel Foods.

Resources

Name	Format	Description	Link
Novel Food Information – 2'-fucosyllactose (2'-FL) from Escherichia coli BL21 (DE3) Strain #1540	HTML		https://www.canada.ca/en/health-canada/services/food-nutrition/genetically-modified-foods-other-novel-foods/approved-products/2-fucosyllactose-escherichia-coli-bl21/technical-summary.html
Novel Food Information – 2'-fucosyllactose (2'-FL) from Escherichia coli BL21 (DE3) Strain #1540	HTML		https://www.canada.ca/fr/sante-canada/services/aliments-nutrition/aliments-genetiquement-modifies-autres-aliments-nouveaux/produits-approuves/2-fucosyllactose-escherichia-coli-bl21/resume-technique.html

Tags

Topics

Categories